295 related articles for article (PubMed ID: 25541960)
21. [Clinical observation of the subthreshold micropulse laser combined with ranibizumab for treatment of diabetic macular edema].
Gu XY; Song S; Dai H; Yu XB
Zhonghua Yan Ke Za Zhi; 2024 Jul; 60(7):570-579. PubMed ID: 38955759
[No Abstract] [Full Text] [Related]
22. Effect of Leaking Foveal Microaneurysms on the Treatment of Center-Involving Diabetic Macular Edema: A Pilot Study.
Hirano T; Toriyama Y; Iesato Y; Ishibazawa A; Sugimoto M; Takamura Y; Nagaoka T; Murata T
Ophthalmic Res; 2019; 61(1):10-18. PubMed ID: 30304729
[TBL] [Abstract][Full Text] [Related]
23. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
[TBL] [Abstract][Full Text] [Related]
25. Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study.
Campochiaro PA; Wykoff CC; Singer M; Johnson R; Marcus D; Yau L; Sternberg G
Ophthalmology; 2014 Dec; 121(12):2432-42. PubMed ID: 25060610
[TBL] [Abstract][Full Text] [Related]
26. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Nguyen QD; Brown DM; Marcus DM; Boyer DS; Patel S; Feiner L; Gibson A; Sy J; Rundle AC; Hopkins JJ; Rubio RG; Ehrlich JS;
Ophthalmology; 2012 Apr; 119(4):789-801. PubMed ID: 22330964
[TBL] [Abstract][Full Text] [Related]
27. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
Rajendram R; Fraser-Bell S; Kaines A; Michaelides M; Hamilton RD; Esposti SD; Peto T; Egan C; Bunce C; Leslie RD; Hykin PG
Arch Ophthalmol; 2012 Aug; 130(8):972-9. PubMed ID: 22491395
[TBL] [Abstract][Full Text] [Related]
28. Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy.
Lucena CR; Ramos Filho JA; Messias AM; Silva JA; Almeida FP; Scott IU; Ribeiro JA; Jorge R
Arq Bras Oftalmol; 2013; 76(1):18-20. PubMed ID: 23812521
[TBL] [Abstract][Full Text] [Related]
29. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
Naser H; Koss MJ; Singh P; Koch F
Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
[TBL] [Abstract][Full Text] [Related]
30. Early Response to Ranibizumab Is Associated with 12-Month Outcome in Diabetic Macular Edema after Prior Macular Laser Therapy.
Sheu SJ; Lee YY
Ophthalmologica; 2017; 238(3):139-146. PubMed ID: 28715811
[TBL] [Abstract][Full Text] [Related]
31. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results.
Larsen M; Schmidt-Erfurth U; Lanzetta P; Wolf S; Simader C; Tokaji E; Pilz S; Weisberger A;
Ophthalmology; 2012 May; 119(5):992-1000. PubMed ID: 22424834
[TBL] [Abstract][Full Text] [Related]
32. A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
Michaelides M; Kaines A; Hamilton RD; Fraser-Bell S; Rajendram R; Quhill F; Boos CJ; Xing W; Egan C; Peto T; Bunce C; Leslie RD; Hykin PG
Ophthalmology; 2010 Jun; 117(6):1078-1086.e2. PubMed ID: 20416952
[TBL] [Abstract][Full Text] [Related]
33. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
[TBL] [Abstract][Full Text] [Related]
34. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.
Mitchell P; Bressler N; Tolley K; Gallagher M; Petrillo J; Ferreira A; Wood R; Bandello F;
JAMA Ophthalmol; 2013 Oct; 131(10):1339-47. PubMed ID: 23974915
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.
Callanan DG; Gupta S; Boyer DS; Ciulla TA; Singer MA; Kuppermann BD; Liu CC; Li XY; Hollander DA; Schiffman RM; Whitcup SM;
Ophthalmology; 2013 Sep; 120(9):1843-51. PubMed ID: 23706947
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
[TBL] [Abstract][Full Text] [Related]
37. The effect of photocoagulation in ischemic areas to prevent recurrence of diabetic macular edema after intravitreal bevacizumab injection.
Takamura Y; Tomomatsu T; Matsumura T; Arimura S; Gozawa M; Takihara Y; Inatani M
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4741-6. PubMed ID: 25028357
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
[TBL] [Abstract][Full Text] [Related]
39. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300
[TBL] [Abstract][Full Text] [Related]
40. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.
Nguyen QD; Shah SM; Heier JS; Do DV; Lim J; Boyer D; Abraham P; Campochiaro PA;
Ophthalmology; 2009 Nov; 116(11):2175-81.e1. PubMed ID: 19700194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
